Online inquiry

IVTScrip™ mRNA-Human ASB9, (Cap 1, 2-Thio-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK26301MR)

This product GTTS-WK26301MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 2-Thio-UTP. It ecodes the ASB9 protein. This product can be used in Retinoid acid signaling-responsive fetal germ cell-related researches.
Specifications
Product type mRNA
Modified bases 2-Thio-UTP
5' Cap Cap 1
Species Human
RefSeq NM_001031739.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 140462
UniProt ID Q96DX5
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ASB9, (Cap 1, 2-Thio-UTP, 120 nt-poly(A)) (GTTS-WK26301MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK11659MR IVTScrip™ mRNA-Human ADORA2A, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADORA2A
GTTS-WK11662MR IVTScrip™ mRNA-Human ADORA3, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ADORA3
GTTS-WK26832MR IVTScrip™ mRNA-Human ARL1, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARL1
GTTS-WK10657MR IVTScrip™ mRNA-Human ACTA2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ACTA2
GTTS-WK23218MR IVTScrip™ mRNA-Human ARHGEF38, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ARHGEF38
GTTS-WK20332MR IVTScrip™ mRNA-Human ANKRD6, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ANKRD6
GTTS-WK19416MR IVTScrip™ mRNA-Human ANKRD30BP2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ANKRD30BP2
GTTS-WK14008MR IVTScrip™ mRNA-Human ADAMTSL1, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ADAMTSL1
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →